Company News
- [News Brief] Samsung Biologics showcases CDO capabilities at BPI 2023
- [Media Focus] Accelerating Biologics Manufacturing: Strategies for Efficient Production Timelines
- [Press Releases] Samsung Biologics announces expanded strategic agreement with Bristol Myers Squibb to manufacture antibody cancer drug substance
- [News Brief] Samsung Biologics joins strategic investment in and pursues a research collaboration with AimedBio to foster next-generation biotechnologies